Age at Menarche and Breast Cancer Characteristics in Women in the Democratic Republic of Congo (DRC) Menarche age and breast cancer in DRC

Nicole Mbombo Mwale (1), Tacite Kpanya Mazoba (2), Antoine Molua Aundu (3), Gertrude Luyeye Mvila (4)
(1) Department of Medical Imaging and Radiology, University of Kinshasa, Kinshasa, DR, Congo, Congo, The Democratic Republic of the,
(2) Department of Medical Imaging and Radiology, University of Kinshasa, Kinshasa, DR, Congo; Interdisciplinary Center for Research in Medical Imaging (CIRIMED), University of Kinshasa, Kinshasa, DR, Congo, Congo, The Democratic Republic of the,
(3) Department of Medical Imaging and Radiology, University of Kinshasa, Kinshasa, DR, Congo; Interdisciplinary Center for Research in Medical Imaging (CIRIMED), University of Kinshasa, Kinshasa, DR, Congo, Congo,
(4) Department of Medical Imaging and Radiology, University of Kinshasa, Kinshasa, DR, Congo; Interdisciplinary Center for Research in Medical Imaging (CIRIMED), University of Kinshasa, Kinshasa, DR, Congo; Centre d’imagerie du Congo (CEIMEC), University of Kinshasa, Kinshasa, DR, Congo; Centre Pilote d’imagerie Médicale Kokolo (CEPIM), University of Kinshasa, Kinshasa, DR, Congo, Congo, The Democratic Republic of the

Abstract

Background: Early menarche has been associated with an increased risk of breast cancer, but the relationship remains poorly understood in resource-limited settings. This study aims to explore the association between age at menarche and breast cancer in the Democratic Republic of the Congo (DRC).


Methods: We conducted a retrospective analysis of 401 breast cancer patients, assessing their age at menarche and clinical characteristics. Data were analyzed using ANOVA to compare mean age at menarche across different clinical and histological subtypes, with significance set at p < 0.05.


Results: The mean age at menarche was 12.7 ± 3.1 years. Significant differences were observed in age at menarche between tumor subtypes, with earlier menarche associated with aggressive subtypes, such as HER2-positive and triple-negative breast cancer. Women with menarche at age ≤12 years had a higher risk of developing breast cancer, consistent with findings from other populations.


Conclusion: Our study suggests that early menarche may be a key factor in breast cancer risk in a resource-limited setting. Identifying women with early menarche could help prioritize them for targeted public health interventions and early screening, particularly in environments where advanced diagnostic tools are scarce. Further research is needed to validate these findings in larger, longitudinal studies across diverse African populations.

Full text article

Generated from XML file

References

Colditz Graham A, Heather J Baer, Tamimi Rulla M. 'Breast Cancer', in David Schottenfeld, and Joseph F. Fraumeni (eds), Cancer Epidemiology and Prevention, 3rd edn (New York, 2006; online edn, Oxford Academic, 1 Sept. 2009), doi:10.1093/acprof:oso/9780195149616.003.0051.

Boffetta, P., Collatuzzo, G. Cancer Epidemiology. In: Ahrens, W., Pigeot, I. (eds) Handbook of Epidemiology. Springer, New York, NY. doi:10.1007/978-1-4614-6625-3_36-1.

Brinton LA, Figueroa JD, Awuah B, Yarney J, Wiafe S, Wood SN, et al. Breast cancer in Sub-Saharan Africa: opportunities for prevention. Breast Cancer Res Treat. 2014 Apr;144(3):467-78. doi: 10.1007/s10549-014-2868-z.

Su CH, Chang WS, Hu PS, Hsiao CL, Ji HX, Liao CH, et al. Contribution of DNA Double-strand Break Repair Gene XRCC3 Genotypes to Triple-negative Breast Cancer Risk. Cancer Genomics Proteomics. 2015 Nov-Dec;12(6):359-67.

Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol. 2012;13(11):1141-51. doi: 10.1016/S1470-2045(12)70425-4.

Actis AM, Bergoc RM, Quartucci Á, Outomuro D. Factores de riesgo convencionales y emergentes en cáncer de mama: un estudio en pacientes posmenopáusicas. Rev Chil Obstet Ginecol. 2009;74(3):135-42. doi: 10.4067/S0717-75262009000300002.

Chen L, Li CI, Tang MT, Porter P, Hill DA, Wiggins CL, et al. Reproductive factors and risk of luminal, HER2-overexpressing, and triple-negative breast cancer among multiethnic women. Cancer Epidemiol Biomarkers Prev. 2016;25(9):1297-304. doi: 10.1158/1055-9965.EPI-15-1104.

Korzets Y, Yariv O, Mutai R, Moore A, Shochat T, Yerushalmi R, et al. The impact of endogenous estrogen exposures on the characteristics and outcomes of estrogen receptor positive, early breast cancer. Discov Oncol. 2021;12(1):26. doi: 10.1007/s12672- 021-00420-x.

Sun YS, Zhao Z, Yang ZN, Xu F, Lu HJ, Zhu ZY, et al. Risk factors and preventions of breast cancer. Int J Biol Sci. 2017;13(11):1387-97. doi: 10.7150/ijbs.21635.

Mashinda KD, Kayembe KP et Mapatano MA. (2012) Prévalence du cancer en République Démocratique du Congo : données anatomopathologiques recueillies aux Cliniques Universitaires et à l’Hôpital Général de Référence de Kinshasa. Ann. Afr. Med., Vol. 5, N° 3, 1087-93

Luyeye Mvila G, Batalansi D, Praet M, Marchal G, Laenen A, Christiaens MR, et al. Prognostic features of breast cancer differ between women in the Democratic Republic of Congo and Belgium. Breast. 2015 Oct;24(5):642-8. doi: 10.1016/j.breast.2015.07.031.

Sulu SMM, Mukuku O, Sulu AMS, Massamba BL, Mashinda DK, Tshimpi AW. Knowledge regarding breast cancer among Congolese women in Kinshasa, Democratic Republic of the Congo. Cancer Rep (Hoboken). 2023 Mar;6(3):e1758. doi: 10.1002/cnr2.1758.

Minouche C, Mukaya J, Mbongo A, Mbongo A, Luyeye G, Mazoba T, et al. Contribution of Mammography in the Screening of Suspicious Breast Cancer Lesions in Congolese Women in Kinshasa. Asian Pacific Journal of Cancer Care. 8, 1 (Mar. 2023), 59-64. doi:10.31557/apjcc.2023.8.1.59-64.

Maseb'a Mwang Sulu S, Batalansi DB, Sulu AMS, Mukuku O, Mboloko JE, Mashinda DK, et al. Immunohistochemical Features of Breast Cancer Seen in Women in Kinshasa, Democratic Republic of the Congo: A Six-Year Retrospective Study. Int J Breast Cancer. 2022 Aug 5;2022:8860947. doi: 10.1155/2022/8860947.

Weigelt B, Geyer FC, Reis-Filho JS. Histological types of breast cancer: how special are they? Mol Oncol. 2010 Jun;4(3):192-208. doi: 10.1016/j.molonc.2010.04.004.

Smolarz B, Nowak AZ, Romanowicz H. Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature). Cancers (Basel). 2022 May 23;14(10):2569. doi: 10.3390/cancers14102569.

Wysocka J. New WHO classification of breast tumours - as published in 2019. Nowotwory J Oncol. 2020;70(6):250-2. doi: 10.5603/NJO.a2020.0038

Brinton LA, Awuah B, Nat Clegg-Lamptey J, Wiafe-Addai B, Ansong D, Nyarko KM, et al. Design considerations for identifying breast cancer risk factors in a population-based study in Africa. Int J Cancer. 2017 Jun 15;140(12):2667-2677. doi: 10.1002/ijc.30688

Lacroix AE, Gondal H, Shumway KR, Langaker MD. Physiology, Menarche. 2023 Mar 11. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.

Arifin H, Chou KR, Ibrahim K, Fitri SUR, Pradipta RO, Rias YA, et al. Analysis of Modifiable, Non-Modifiable, and Physiological Risk Factors of Non-Communicable Diseases in Indonesia: Evidence from the 2018 Indonesian Basic Health Research. J Multidiscip Healthc. 2022 Sep 30;15:2203-2221. doi:10.2147/JMDH.S382191.

Endah Zuraidah, Nur Fitrianingsih Pujiano Agatha, Sarah Qanita Edwar, Supri Irianti Handayani. Correlation Between Age at Menarche and Breast Cancer Incidence in Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia (2010-2014). Asian Pac J Cancer Care, 8 (3), 459-464. doi:10.31557/APJCC.2023.8.3.459.

Authors

Nicole Mbombo Mwale
Tacite Kpanya Mazoba
Antoine Molua Aundu
Gertrude Luyeye Mvila
gluyeye.gl@gmail.com (Primary Contact)
1.
Mbombo Mwale N, Kpanya Mazoba T, Molua Aundu A, Luyeye Mvila G. Age at Menarche and Breast Cancer Characteristics in Women in the Democratic Republic of Congo (DRC): Menarche age and breast cancer in DRC. Arch Breast Cancer [Internet]. [cited 2025 Jun. 18];12(3). Available from: https://archbreastcancer.com/index.php/abc/article/view/1097

Article Details